PROSTATE NEOPLASM
Clinical trials for PROSTATE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new PROSTATE NEOPLASM trials appear
Sign up with your email to follow new studies for PROSTATE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less medicine be just as good? prostate cancer study tests lower doses
Disease control TerminatedThis study aimed to find the lowest effective dose of the prostate cancer drug abiraterone. Researchers tested if taking a lower dose less frequently (like every other day or a few times a week) worked as well as the standard daily dose. The goal was to maintain cancer control wh…
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Early cancer drug trial halted before key testing phase
Disease control TerminatedThis early-stage study tested a new oral cancer drug called NUV-868, both alone and combined with existing medications (olaparib or enzalutamide), in adults with advanced solid tumors. The trial aimed to find safe doses and see if these treatments could help control cancers that …
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC